8-KOther EventsExhibits & Filings

AGILENT TECHNOLOGIES, INC. 8-K Report, Corporate Update (Dec 21, 2009)

Filed December 21, 2009For Securities:A

Summary

Agilent Technologies, Inc. (Agilent) is announcing a change in its business segment reporting structure, effective November 1, 2009. Beginning in the first quarter of fiscal year 2010, the company will report results across three distinct business segments: Electronic Measurement, Life Sciences, and Chemical Analysis. This restructuring is based on how Agilent's chief operating decision maker views and evaluates the company's operations for resource allocation and performance assessment. The change involves reclassifying existing business units, with the Life Sciences and Chemical Analysis segments being formed from the former Bio-Analytical Measurement segment, and the Electronic Measurement segment being recombined with the former Semiconductor Board Test segment. This Form 8-K provides investors with updated historical segment financial information for fiscal years 2007, 2008, and 2009, presented on a basis consistent with the new reporting structure. While the segment reporting is adjusted retrospectively, it does not involve a restatement of Agilent's overall GAAP Consolidated Financial Statements. Investors should note that this change primarily affects how financial performance will be presented and analyzed going forward, offering a clearer view of operational performance within these redefined segments.

Key Highlights

  • 1Agilent Technologies is changing its business segment reporting structure, effective November 1, 2009.
  • 2The company will now report in three segments: Electronic Measurement, Life Sciences, and Chemical Analysis.
  • 3The Life Sciences and Chemical Analysis segments are formed from the former Bio-Analytical Measurement segment.
  • 4The Electronic Measurement segment will be recombined with the former Semiconductor Board Test segment.
  • 5This change reflects how the chief operating decision maker views and evaluates the company's operations.
  • 6Historical segment financial data for fiscal years 2007-2009 is being provided retrospectively to align with the new structure.
  • 7The overall GAAP Consolidated Financial Statements are not being restated.

Frequently Asked Questions

The main purpose of this Form 8-K is to inform investors about Agilent Technologies' change in its business segment reporting structure, effective November 1, 2009, and to provide historical segment financial data that aligns with this new structure.

Agilent will now report results in three business segments: Electronic Measurement, Life Sciences, and Chemical Analysis. These segments are determined by how the company's chief operating decision maker manages and evaluates the business.

No, this change in segment reporting affects only how results are categorized and presented by segment. It does not involve a revision or restatement of Agilent's overall GAAP Consolidated Financial Statements (Consolidated Statements of Earnings, Balance Sheets, Shareholders' Equity, or Cash Flows) for any period.

Yes, the segment reporting change will be reflected retrospectively. Agilent is providing summary financial information and historical data for fiscal years 2007, 2008, and 2009 on a basis consistent with the new reporting structure to aid investor understanding.